LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Oncology Focus TESARO is dedicated to developing advanced oncology therapies, including a subcutaneous formulation of dostarlimab, indicating strong potential for partnerships with healthcare providers and clinics seeking cutting-edge cancer treatments.

Pipeline Expansion The company's ongoing development of Jemperli and other immunotherapy drugs presents opportunities to engage with specialty hospitals and research institutions interested in innovative solid tumor treatments.

Recent Collaborations TESARO’s collaboration agreements and licensing deals, such as with Alteogen, suggest that there may be strategic partnership opportunities with biotech firms and contract research organizations aiming to expand their oncology pipelines.

Financial Capacity With a funding amount of $409 million and revenues between $50 million and $100 million, TESARO is positioned to invest in new product launches and clinical trials, creating sales prospects with healthcare institutions and distributors.

Technological Edge TESARO’s adoption of advanced technology stack including TensorFlow and new relic indicates a focus on data-driven research and digital engagement, opening avenues for tech-focused healthcare solutions and digital health collaborations.

TESARO, Inc. Tech Stack

TESARO, Inc. uses 8 technology products and services including CAPTCHA, Font Awesome, AngularJS, and more. Explore TESARO, Inc.'s tech stack below.

  • CAPTCHA
    Captcha
  • Font Awesome
    Font Scripts
  • AngularJS
    Javascript Frameworks
  • TensorFlow
    Machine Learning
  • SWFObject
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Linux
    Programming Languages
  • New Relic
    Real User Monitoring

Media & News

TESARO, Inc.'s Email Address Formats

TESARO, Inc. uses at least 1 format(s):
TESARO, Inc. Email FormatsExamplePercentage
FLast@tesarobio.comJDoe@tesarobio.com
85%
FirstLast@tesarobio.comJohnDoe@tesarobio.com
9%
First.Last@tesarobio.comJohn.Doe@tesarobio.com
6%

Frequently Asked Questions

Where is TESARO, Inc.'s headquarters located?

Minus sign iconPlus sign iconTESARO, Inc.'s main headquarters is located at 1000 Winter Street Waltham, Massachusetts 02451 United States. The company has employees across 3 continents, including North AmericaEuropeAfrica.

What is TESARO, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact TESARO, Inc.'s main corporate office by phone at
+1-339-970-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is TESARO, Inc.'s stock symbol?

Minus sign iconPlus sign iconTESARO, Inc. is a publicly traded company; the company's stock symbol is TSRO.

What is TESARO, Inc.'s official website and social media links?

Minus sign iconPlus sign iconTESARO, Inc.'s official website is tesarobio.com and has social profiles on LinkedInCrunchbase.

What is TESARO, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconTESARO, Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does TESARO, Inc. have currently?

Minus sign iconPlus sign iconAs of March 2026, TESARO, Inc. has approximately 52 employees across 3 continents, including North AmericaEuropeAfrica. Key team members include VP Global Clinical Development: S. C.Executive Assistant- Cco: J. M.Vice President, General Manager Dach: B. S.. Explore TESARO, Inc.'s employee directory with LeadIQ.

What industry does TESARO, Inc. belong to?

Minus sign iconPlus sign iconTESARO, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does TESARO, Inc. use?

Minus sign iconPlus sign iconTESARO, Inc.'s tech stack includes CAPTCHAFont AwesomeAngularJSTensorFlowSWFObjectMicrosoftLinuxNew Relic.

What is TESARO, Inc.'s email format?

Minus sign iconPlus sign iconTESARO, Inc.'s email format typically follows the pattern of FLast@tesarobio.com. Find more TESARO, Inc. email formats with LeadIQ.

How much funding has TESARO, Inc. raised to date?

Minus sign iconPlus sign icon As of March 2026, TESARO, Inc. has raised $409M in funding. The last funding round occurred on Jun 30, 2016 for $409M.

TESARO, Inc.

Pharmaceutical ManufacturingMassachusetts, United States51-200 Employees

TESARO is an oncology-focused business within GlaxoSmithKline (GSK) with a clear mission that drives all of our actions. We are dedicated to improving the oncology experience and have a passionate commitment to unconditional care, which puts science for patients first. At TESARO, we bring together working lives and human lives, inspiring future leaders, and building lasting careers. It’s a commitment we make to each member of our team. We care for you, so you can unconditionally care for people living with cancer.

Section iconCompany Overview

Headquarters
1000 Winter Street Waltham, Massachusetts 02451 United States
Phone number
+1-339-970-****
Website
tesarobio.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
TSRO
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $409M

    TESARO, Inc. has raised a total of $409M of funding over 8 rounds. Their latest funding round was raised on Jun 30, 2016 in the amount of $409M.

  • $50M$100M

    TESARO, Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $409M

    TESARO, Inc. has raised a total of $409M of funding over 8 rounds. Their latest funding round was raised on Jun 30, 2016 in the amount of $409M.

  • $50M$100M

    TESARO, Inc.'s revenue is estimated to be in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    S. C.
    VP Global Clinical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. M.
    Executive Assistant- Cco
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. S.
    Vice President, General Manager Dach
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. D.
    Senior Vice President Global Commercial Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. J.
    Sr. Vp Regulatory Affairs And Quality Assurance
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    P. S.
    Associate Director, Gcp/Glp Quality Assurance
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. L.
    Corporate Accounts Director, Payer Team - Market Access
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. B.
    Regional Area Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. W.
    Director, Global Brand Analytics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. W.
    Director Regulatory Cmc
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.